Linked In       FaceBook       Twitter       You Tube
Project management using Podio



Advocacy Home Page

AMP Press Releases

AMP Position Statements and Letters





Association for Molecular Pathology

AMP Position Statements and Letters - 2014



2014 Title Keywords Committee
December 17 Group Letter to Palmetto Regarding Concerns with DLCD: Molecular Diagnostic Tests (DL33599)

Palmetto, LCD, MOLDX, MDT, MAC, Medicare, CMS, CPT code, CAP


Economic Affairs
December 17 Comments to Palmetto Regarding the Classification of CDH1 Genetic Testing (M00087)

Palmetto, CDH1, Medicare, CMS, HDGC, MOLDX, LCD


Economic Affairs
November 18

Group letter to the FDA asking for a withdrawal of proposed draft guidance seeking to regulate laboratory developed tests (LDTs)


LDT, FDA, AMA Professional Relations
September 9

Testimony for Energy and Commerce Hearing on "21st Century Cures: Examining the Regulation of Laboratory Developed Tests"


LDT, FDA, LDP, CLIA Professional Relations
September 8

Group Letter to Congress opposing S. 1347


S. 1347, federal employee travel Multiple Organizations
September 2

Comments to the CMS CY2015 Proposed Physician Fee Schedule (PFS) Rule


Medicare, CLFS, LCD, Palmetto MolDx


Economic Affairs
July 30

Comments to the USPTO on the draft Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of Nature, Natural Phenomena & Natural Products


Mayo, Myriad, patent Professional Relations
July 29

Letter to Congress requesting S. 1347 exempt scientific and medical conferences


S. 1347, federal employee travel Professional Relations
July 3

Comments on Section 1834A of the Protecting Access to Medicare Act of 2014


PAMA, CMS, CLIA Professional Relations
June 1

Response to the "21st Century Cures: A Call to Action" request for comments


FDA, CLIA, LDP, HUGO, CMS, federal employee travel


Professional Relations
May 13 Letter to FDA regarding HPV Indications for Use FDA, HPV

Professional Relations


March 27 Letter to Sen Harry Reid regarding sweeping changes to the CLFS in SGR patch legislation. CLFS, CMS, CPT, SGR

Economic Affairs &

Professional Relations


February 18

Draft Guidance for Industry: Recommendations for Premarket
Notification (510(k)) Submissions for Nucleic Acid-Based Human Leukocyte Antigen (HLA) Test Kits Used for Transfusion and Transplantation


FDA, ASHI Professional Relations
January 27

Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical

Laboratory Fee Schedule, and Other Revisions to Part B for CY 2014, Final Rule (CMS-1600-FC)
CMS, PFS, CLFS Economic Affairs